Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/guangzhou-lupengnewave-pharmaceutical-inc-enrolled-the-first-patient-in-the-global-phase-3-rocket-cll-trial-evaluating-rocbrutinib-lp-168-vs-pirtobrutinib-in-rr-cllsll-302779014.html

PR NEWSWIRE
21 May 2026